CVS Health just gave the market a fresh jolt of confidence.

The company raised its 2025 profit guidance again and forecast 2026 adjusted earnings of 7.00 to 7.20 dollars per share, slightly above Wall Street expectations, driven by stronger margins at its Aetna insurance arm and its Caremark pharmacy-benefit business. It expects at least 400 billion dollars of revenue in 2026 and plans to keep tightening costs and exiting weaker lines.

CVS also confirmed it will pull out of Obamacare exchange plans in 2026, underscoring how rising medical costs are squeezing some insurers in that space.

Winners

Winners – Integrated healthcare giants

Reason: CVS has shown that a big, diversified model (insurance plus PBM plus pharmacies) can still grow earnings even with cost pressure, which supports similar nam ...